We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Restasis Is FDA-Approved, Allergan Reminds Compounder

Law360, New York (January 11, 2018, 8:22 PM EST) -- Allergan USA Inc. on Wednesday urged a California federal court to shoot down false advertising counterclaims brought by drug compounder Imprimis Pharmaceuticals Inc., arguing that it’s factually true that its dry-eye...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


California Central

Nature of Suit

890(Other Statutory Actions)


Subscribers Only

Date Filed

September 7, 2017

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.